Trademarkia Logo

Australia

AU$
Trademark Search
PYLSCAN

View On IPO.GOV.AU

PYLSCAN
Cancelled: Cancelled at the request of IB

Last updated on 27 Mar 2024

Owner Info

Progenics Pharmaceuticals, Inc.

331 Treble Cove Road

North Billerica MA 01862, UNITED STATES OF AMERICA

Serial Number

2086493 filed on 6 Apr 2020

Correspondent

Douglas R. Wolf

Wolf, Greenfield & Sacks, P.C.,,

600 Atlantic Avenue,

UNITED STATES OF AMERICA

PYLSCAN

Classification Information

Class [005]
Radiopharmaceutical imaging and detection agents for detection, diagnosing and monitoring cancer; pharmaceutical preparations for the detection, diagn Read More

Class [042]
Scientific research and development in the nature of research, development and preparation of pharmaceutical drugs and imaging agents for medical use; Read More

Class [044]
Providing medical testing services and information in the field of cancer diagnosis, treatment and prevention; web-based medical testing for identific Read More

Mark Details

Serial Number

2086493

Registered On

6 Apr 2020

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)

Date

8 Oct 2019

Mark Type

US

Legal History

Show more

Status DateAction Taken
27th Mar 2024Status change to Voided
26th Jan 2023Amendment to Amend Owner Requested
26th Nov 2020Amendment to International Registration Contact Requested
10th Sept 2020International Registration in Australia Protected correspondence sent
9th Sept 2020IP Right Registration Published
9th Sept 2020Status change to Registered/Protected
3rd Jul 2020Application Accepted correspondence sent
2th Jul 2020IP Right has been Examined
2th Jul 2020IP Right Acceptance Published
2th Jul 2020Status change to Accepted